Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
bristol-myers squibb
fda
merck
roche
abbvie
alzheimer's disease
astrazeneca
cancer
cancer immunotherapy
What
bio
roundup
crispr
days
acquisitions
albert
alliance
annual
ash
august
barcelona
biggest
biotech
bourla
bristol
busy
buy
calls
cancer
ceo
changing
clinical
color
company
conference
december's
decisions
devices
drug
drugs
esmo
european
fda
future
growing
hours
imports
kras
kudos
leaves
Language
unset
unknown
Current search:
amgen
×
glaxosmithkline
×
pfizer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
